SEC Form 4 · accession 0001209191-18-058305
Outlook Therapeutics, Inc. · OTLK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joerg Windisch
Director
Period of report
Nov 9, 2018
Accepted (ET)
Nov 13, 2018 · 4:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001649989
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2,F1 | $0.89 | Nov 9, 2018 | A | 130,465 | A | — | Nov 9, 2028 | Common Stock | 130,465 | 130,465 | D |
Explanation of responses
- F1Immediately exercisable.
- F2This option was issued to the Reporting Person pursuant to the Issuer's 2015 Equity Incentive Plan in lieu of two years of cash retainer and meeting fees of $80,000.